Dr. Jan Kirsten
Angestellt, President & Managing Director at Merck Italy, Merck KGaA; Merck Serono Italia s.p.a
Rome, Italien
Über mich
As an experienced manager, I possess in-depth know-how in business development and organizational leadership. I competently implement efficient innovation programs to thrive in a complex environment. My track record includes expanding portfolios, increasing profitability, and achieving substantial business growth. The combination of my background in biology and business has proven to be valuable, as it enables me to make sensible decisions, for instance in the following fields: • Strategically transforming business operations • Driving profitable growth • Transforming businesses I attach particular importance to an atmosphere that is both encouraging and challenging. With my strong entrepreneurial focus, I successfully identify optimization potentials and exploit them efficiently. My leadership approach benefits from working with global interdisciplinary teams, my intercultural sensitivity and multilingual communication skills across all hierarchical levels.
Werdegang
Berufserfahrung von Jan Kirsten
Bis heute 3 Jahre, seit Juni 2021
President & Managing Director at Merck Italy
Merck KGaA; Merck Serono Italia s.p.a
• Holding full strategic, operational, financial, and legal accountability across all functions and therapeutic areas • Managing the full P&L • Legal responsible for 1200 employees across 4 sites
3 Jahre und 5 Monate, Apr. 2018 - Aug. 2021
SVP, Global Head of Fertility Franchise
Merck Biopharma
• Leading the Global Fertility Franchise and driving the evolution towards a fully integrated portfolio (Tx, Dx, Services and Digital Health) • Overseeing the end-to-end global strategy and operative business performance, incl. portfolio expansion (Tx, Dx, DH), product development, global P&L, and all mid- to long-term operational aspects Key Achievements: • Expanding the global therapeutic and technology portfolio • Achieving a significant Year-over-Year profitable growth
4 Jahre und 1 Monat, Apr. 2014 - Apr. 2018
VP, Global Head of Fertility Technologies
Merck Biopharma
• Setting up the entire business from scratch in 3.5 years • Leading the global Fertility Technologies business with global, strategy and P&L responsibility • Developing products as well as managing R&D and the portfolio (HW, SW and services) • Managing in-licensing and the geographic expansion • Monitoring commercial and marketing partnerships Key Achievements: • Expanding the business into more than 20 countries • Launching more than 6 product lines with a total of 28 products
1 Jahr und 3 Monate, Jan. 2013 - März 2014
Head of Global Business Innovation
Siemens Healthcare
• Responsible for setting up and establishing the new unit within Siemens • Leading the new business innovation unit and reporting to the CTO • Developing and testing new business models incl. negotiating and partnering with payors and Top 20 Pharma companies • Establishing the sector IP strategy incl. out-licensing assets Key Achievements: • Successfully setting up the new global organisation from scratch • Established several Big Pharma partnerships & out-licensing deals
1 Jahr, Jan. 2012 - Dez. 2012
Head of Strategy Consulting Group - Siemens Healthcare Consulting
Siemens Healthcare
1 Jahr, Jan. 2011 - Dez. 2011
Head of Merck Group Strategy
Merck KGaA
3 Jahre und 3 Monate, Okt. 2007 - Dez. 2010
Director Inhouse Consulting
Merck KGaA
3 Jahre und 7 Monate, März 2002 - Sep. 2005
Strategy Consultant
Capgemini Strategy Consulting
5 Jahre und 1 Monat, Jan. 1997 - Jan. 2002
Founder & Former Managing Director
anSichten-Verlag
Ausbildung von Jan Kirsten
3 Jahre und 2 Monate, Jan. 2004 - Feb. 2007
Business Management
Ludwig-Maximilians-Universität München
Focus area: Industrial Economics Thesis: Innovation networks between science and technology
2 Jahre und 4 Monate, Okt. 2002 - Jan. 2005
Business Research
Ludwig-Maximilians-Universität München
Major: International Management and Healthcare Systems
3 Monate, Dez. 1999 - Feb. 2000
Developmental Biology and Cancer Research
The University of Auckland
Visiting Research Scholar at the Developmental Biology and Cancer Research Group, School of Biological Sciences, University of Auckland, New Zealand. Research work on the expression of specific calpains in an in vitro model system: the mouse C2C12 cell line
5 Jahre und 5 Monate, Okt. 1996 - Feb. 2002
Biology
Bayerische Julius-Maximilians-Universität Würzburg
Focus area: Molecular Biology
Sprachen
Englisch
Muttersprache
Deutsch
Muttersprache
Italienisch
Grundlagen
Spanisch
Grundlagen